-transparent.png){kind=logo}
A 79-year-old patient with acute myeloblastic leukemia (M2 type in FAB), who has survived more than 5 years, is reported. She was admitted because of fever and anemia. Her white blood cell count was 6200/mm3 with 58% blasts. Bone marrow aspiration showed a nucleated cell count of 26 X 10(4)/mm with 84% blasts, Complete remission was achieved within one month by DCMP two-step method therapy. She relapsed in the third and fifth years after initial therapy. Because leukemic change is atypical, she was treated with a low dose of Ara-C therapy, resulting in complete remission. In cases of acute myelobastic leukemia in elderly patients, long-term survival is rare. However in this case, follow-up has succeeded for 5 years. This patient is the oldest case of acute myeloblastic leukemia ever reported in Japan.
Y Okamoto, and
M Mori, and
A Miyazaki, and
T Oguro, and
T Inada
June 1994,
Revista clinica espanola,
Y Okamoto, and
M Mori, and
A Miyazaki, and
T Oguro, and
T Inada
February 2010,
Annals of oncology : official journal of the European Society for Medical Oncology,
Y Okamoto, and
M Mori, and
A Miyazaki, and
T Oguro, and
T Inada
February 2001,
Leukemia & lymphoma,
Y Okamoto, and
M Mori, and
A Miyazaki, and
T Oguro, and
T Inada
March 1972,
Cancer,
Y Okamoto, and
M Mori, and
A Miyazaki, and
T Oguro, and
T Inada
November 1983,
Gan to kagaku ryoho. Cancer & chemotherapy,
Y Okamoto, and
M Mori, and
A Miyazaki, and
T Oguro, and
T Inada
April 2021,
Medicine,
Y Okamoto, and
M Mori, and
A Miyazaki, and
T Oguro, and
T Inada
October 1998,
Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia,
Y Okamoto, and
M Mori, and
A Miyazaki, and
T Oguro, and
T Inada
September 2010,
The Korean journal of hematology,
Y Okamoto, and
M Mori, and
A Miyazaki, and
T Oguro, and
T Inada
March 1974,
The New England journal of medicine,
Y Okamoto, and
M Mori, and
A Miyazaki, and
T Oguro, and
T Inada
June 2008,
Gan to kagaku ryoho. Cancer & chemotherapy,
